A design for efficient generation of mid-infrared pulses at 3.2 μm is presented, which is based on numerical simulations of the broadband-pumped dual-chirped optical parametric amplification (DC-OPA) in LiNbO doped with 5 mol.% MgO (MgO:LiNbO). The broadband seed can be generated by difference frequency generation in KTA using spectrally-broadened Ti:Sapphire lasers. The broad DC-OPA phase-matching bandwidth-spanning from 2.4 μm to 4.0 μm-is achieved by chirping both the broadband Ti:Sapphire pump pulses and the seed pulses in such a way that the individual temporal slice of pump spectrum is able to phase match that of seed spectrum. This phase matching scheme allows the use of longer crystals without gain narrowing or loss of conversion efficiency. The theoretical conversion efficiency from the pump to the idler reaches 19.1 %, enabling generation of a few hundred mJ of mid-IR energy with an available large-aperture MgO:LiNbO crystal. Furthermore, the commercially available acousto-optic programmable dispersive filter (AOPDF) ensures compression of such a broad bandwidth down to 20 fs (two optical cycles at 3.2 μm).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.24.024989 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intraoperative goal-directed hemodynamic therapy targeting both arterial pressure and flow parameters using uncalibrated pulse contour techniques: A meta-analysis of randomized controlled trials.
Rev Esp Anestesiol Reanim (Engl Ed)
December 2024
Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Hospital Universitario Puerto Real, Cádiz, Spain.
Background: Goal-directed haemodynamic therapy (GDHT) aims to optimize haemodynamic variables. However, its effectiveness in reducing postoperative complications in major abdominal surgery, particularly when targeting both arterial pressure and flow variables, remains unclear. This meta-analysis addresses this by evaluating GDHT using uncalibrated pulse contour (uPC) methods.
View Article and Find Full Text PDFRheological, Fresh State, and Strength Characteristics of Alkali-Activated Mortars Incorporating MgO and Carbon Nanoparticles.
Materials (Basel)
December 2024
Department of Civil Engineering, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada.
This study presents a comprehensive assessment of the fresh state, rheological, and mechanical properties of alkali-activated mortars (AAMs) developed by incorporating magnesium oxide (MgO) and nanomaterials. A total of 24 AAM mixes with varying content of MgO, multi-walled carbon nanotube (MWCNT), and reduced graphene oxide (rGO) were developed following the one-part dry mix technique using powder-based activators/reagents. The effects of the types/combinations of source materials (binary or ternary)/reagents, MgO (0 to 5%), MWCNT (0 to 0.
View Article and Find Full Text PDFInappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Circ Arrhythm Electrophysiol
December 2024
Department of Cardiology, Amsterdam UMC Location University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences Heart failure and Arrhythmias, the Netherlands (L.R.A.O.N., S.P., L.V.A.B., T.F.B., A.-F.B.E.Q., W.v.d.S., L.S., J.A.d.V., J.G.P.T., N.R.B., J.R.d.G., K.M.K., A.d.W., A.A.M.W., R.E.K.).
Article Synopsis
- Inappropriate therapy (IAT) is a significant issue associated with implantable cardiac defibrillator (ICD) therapy, particularly highlighted in early subcutaneous ICD (S-ICD) studies which showed high rates of inappropriate shocks (IAS).
- The PRAETORIAN trial, an international study with 849 patients, found no major differences in IAT and IAS rates between S-ICD and transvenous ICD (TV-ICD) groups, as both groups had similar cumulative incidences.
- Key predictors for IAT varied between the two groups, with TV-ICD patients experiencing IAT mainly from supraventricular tachycardias, while S-ICD patients faced issues from cardiac oversensing
Integrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF).
Circ Cardiovasc Qual Outcomes
December 2024
Adult and Child Center for Outcomes Research & Delivery Science Center, University of Colorado School of Medicine, Aurora, CO. (M.B., D.D.M., K.N., L.A.A.).
Background: Guideline-directed medical therapy for heart failure (HF) with reduced ejection fraction can entail high out-of-pocket (OOP) costs, prompting concerns about financial toxicity and access. OOP costs are generally unavailable during encounters. This trial assessed the impact of providing patient-specific OOP costs to patients and clinicians.
View Article and Find Full Text PDFA randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia.
Am Heart J
November 2024
From the Cardiovascular Critical Care Unit, National Institute of Cardiology Ignacio Chávez, Mexico City, México. Electronic address:
Background: Coronary artery ectasia (CAE) of the culprit infarct artery is a rare finding in patients with acute coronary syndrome (ACS). While anticoagulants have been suggested to reduce recurrent events, the optimal antithrombotic therapy remains unclear.
Methods: OVER-TIME was an open label, exploratory, randomized controlled trial comparing dual antiplatelet therapy (DAPT; acetyl-salicylic-acid 100mg plus clopidogrel 75mg daily) versus single antiplatelet (SAPT, clopidogrel 75mg) plus DOAC (rivaroxaban 15mg) in patients with ACS and CAE.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!